New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Xencor, Inc.
XNCR
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2B

Biotechnology

Next Earning date - 25 Feb 2025

2B

Biotechnology

Next Earning date - 25 Feb 2025

26.60USD
Shape-0.24 ( -0.89%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

47%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

2%

Quote Panel

Shape
Updated December 4, 2024
1W 3.91 % 1M 23.61 % 3M 62.99 % 1Y 42.86 %

Key Metrics

Shape
  • Market Cap

    1.86B


  • Shares Outstanding

    69.98M


  • Share in Float

    65.87M


  • Dividende

    0


  • Earning Date

    25 Feb 2025


  • Price Target

    26.6


  • Average Volume

    590580


  • Beta

    0.656


  • Range

    15.31-27.2


  • Industry

    Biotechnology


  • Website

    https://www.xencor.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

21.86x

P/S Ratio

2.35x

P/B Ratio

0.0

Debt/Equity

-232.8%

Net Margin

$-3.2

EPS

How XNCR compares to sector?

P/E Ratio

Relative Strength

Shape

XNCR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$115M

Shape971%

2025-Revenue

$3.11

Shape-338%

2025-EPS

$34M

Shape46%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cowen & Co.

initialise

Previous: Not converted

2022-12-06

Now: Outperform

Raymond James

upgrade

Previous: Not converted

2022-10-13

Now: Strong Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.20
vs 1.21

Q1.23

arrow
arrow

N/A

-1.02
vs 0.39

Q2.23

arrow
arrow

N/A

-0.37
vs -0.57

Q3.23

arrow
arrow

N/A

-0.40
vs -0.55

Q4.23

arrow
arrow

N/A

-0.31
vs -0.20

Q1.24

arrow
arrow

N/A

-1.11
vs -1.02

Q2.24

arrow
arrow

N/A

-1.07
vs -0.37

Q3.24

arrow
arrow

N/A

-0.71
vs -0.40

Q4.24

arrow
arrow

N/A

-0.81
vs -0.31

Q1.25

arrow
arrow

N/A

-0.88
vs -1.11

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-86%

21.6M  vs 154M

Q1.23

arrow
arrow

-78%

19M  vs 85.5M

Q2.23

arrow
arrow

+51%

45.5M  vs 30.2M

Q3.23

arrow
arrow

+117%

59.2M  vs 27.3M

Q4.23

arrow
arrow

+107%

44.7M  vs 21.6M

Q1.24

arrow
arrow

-32%

12.8M  vs 19M

Q2.24

arrow
arrow

-63%

17M  vs 45.5M

Q3.24

arrow
arrow

-82%

10.7M  vs 59.2M

Q4.24

arrow
arrow

-61%

17.4M  vs 44.7M

Q1.25

arrow
arrow

+16%

14.8M  vs 12.8M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-2%

-0.02
vs -0.05

Q1.23

arrow
arrow

-9%

-0.09
vs -0.02

Q2.23

arrow
arrow

-3%

-0.03
vs -0.09

Q3.23

arrow
arrow

-4%

-0.04
vs -0.03

Q4.23

arrow
arrow

-3%

-0.03
vs -0.04

Q1.24

arrow
arrow

-11%

-0.11
vs -0.03

Q2.24

arrow
arrow

-12%

-0.12
vs -0.11

Q3.24

arrow
arrow

-6%

-0.06
vs -0.12

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

196

196
vs 177

11%

Q1.23

arrow
arrow

189

189
vs 196

-4%

Q2.23

arrow
arrow

182

182
vs 189

-4%

Q3.23

arrow
arrow

176

176
vs 182

-3%

Q4.23

arrow
arrow

195

195
vs 176

11%

Q1.24

arrow
arrow

203

203
vs 195

4%

Q2.24

arrow
arrow

200

200
vs 203

-1%

Q3.24

arrow
arrow

211

211
vs 200

6%

Earnings Growth

Latest News